Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering
Annals of Clinical and Translational Neurology · 2026-11 · 13 (11) · 2206-2216
DOI: 10.1002/acn3.70389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 09.04.2026. Verfasst von Bade Gulec und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkiye. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Demyelinating Autoimmune Diseases, CNS, Multiple Sclerosis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap. Some patients remain double‐seronegative, showing atypical features that challenge current classifications.
Objective
To better characterize the phenotypic spectrum of antibody‐negative atypical inflammatory demyelinating disorders (AIDD) using unsupervised clustering.
Methods
We retrospectively analyzed 316 patients (MS = 164, AQP4 + NMOSD = 36, double‐seronegative NMOSD = 21, MOGAD = 15, AIDD = 80) followed between 2010 and 2023. Principal component analysis and k‐means clustering were applied to AIDD cases using clinical, demographic, and radiological data.
Results
AIDD patients had lower disability and fewer corpus callosum and posterior fossa lesions than MS and NMOSD. Three clusters emerged: (1) myelitis‐predominant with unmatched CSF oligoclonal bands and longitudinally extensive spinal lesions, (2) brainstem‐dominant with recurrent brainstem attacks, and (3) optic neuritis‐dominant with recurrent LEON meeting MS dissemination criteria. Treatment patterns differed; rituximab was most frequent.
Conclusion
Double‐seronegative AIDD represents a heterogeneous clinical spectrum. Unsupervised clustering provides a data‐driven framework for refining phenotypic classification and may support biomarker and therapeutic development in antibody‐negative CNS demyelination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkiye.
- Department of Biostatistics and Medical Informatics, Faculty of Medicine, Akdeniz University, Antalya, Turkiye.
ORCID-Profile: Bade Gulec, Melih Tutuncu
Zitieren
APA
Gulec, B., Everest, E., Tutuncu, M., Bilge, U., Saip, S., Uygunoglu, U., & Siva, A. (2026). Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering. Annals of Clinical and Translational Neurology, 13(11), 2206-2216. https://doi.org/10.1002/acn3.70389
Vancouver
Gulec B, Everest E, Tutuncu M, Bilge U, Saip S, Uygunoglu U, et al. Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering. Annals of Clinical and Translational Neurology. 2026;13(11):2206-2216. doi:10.1002/acn3.70389
BibTeX
@article{Gulec2026,
author = {Gulec, Bade and Everest, Elif and Tutuncu, Melih and Bilge, Ugur and Saip, Sabahattin and Uygunoglu, Ugur and Siva, Aksel},
title = {Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
volume = {13},
number = {11},
pages = {2206--2216},
doi = {10.1002/acn3.70389}
}
EUVIMED